15 Nov, 2021
Astellas and Pantherna Enter into Technology Evaluation Agreement for Research of mRNA-based Regenerative Medicine.
Posted at 13:51h
in Allgemein
Under this agreement, Pantherna’s state-of-art mRNA platform and Astellas’ high drug discovery capabilities will be utilized to promote research on the field of regenerative medicine.
backFULL TEXT (EN)